InvestorsHub Logo
Post# of 4973296
Next 10
Followers 28
Posts 10859
Boards Moderated 0
Alias Born 01/28/2005

Re: None

Monday, 02/06/2006 10:26:09 AM

Monday, February 06, 2006 10:26:09 AM

Post# of 4973296
EFSF: eFoodSafety.com, Inc. Subsidiary, Knock-Out Technologies, Ltd. Readies Third Ingestible Product for Independent Laboratory Testing
Monday February 6, 9:30 am ET
New Knock-Out Formula Targets Lyme Disease


SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Feb. 6, 2006--Robert Bowker, President/CEO of Knock-Out Technologies, Ltd., a wholly owned subsidiary of eFoodSafety.com, Inc. (OTCBB:EFSF - News), announced today that the company has created a safe, natural, ingestible product that can eradicate Lyme disease.
ADVERTISEMENT


The company anticipates commencing human clinical trials using the Lyme disease product within the next 30 days. Human clinical trials have already commenced on the first ingestible product, the Avian Influenza formula. The second ingestible product, the Candida Albicans formula, which kills the most common fungal infection in immunosuppressed patients, is scheduled to undergo human clinical trials shortly.

Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans by the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. Lyme disease is diagnosed based on symptoms, physical findings (e.g., rash), and the possibility of exposure to infected ticks; laboratory testing is helpful in the later stages of disease. The ticks that transmit Lyme disease can occasionally transmit other tick-borne diseases as well (Division of Vector-Borne Infectious Diseases; National Center for Infectious Diseases; Centers for Disease Control and Prevention; http://www.cdc.gov).

"Based on the increasing incidence of Lyme disease and its prolonged debilitating symptoms, we feel our product will have a major impact on this serious health threat. We will pursue human clinical trials to prove our groundbreaking technology is effective in eradicating Lyme disease," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.